Predicting cisplatin tolerability in older adults with head and neck cancer - Insights for improved chemoradiation outcomes.
Rühle A, Weymann M, Behrens M, Olbrich J, Kut C, Marschner SN, Haderlein M, Fabian A, Senger C, Bakst BP, Kraft J, von der Grün J, Looman EL, Chen E, Domschikowski J, Altay-Langguth A, Kalinauskaite G, Lewitzki V, Bonomi M, Blakaj D, Jhawar SR, Baliga S, Elguindy ANMH, Ferentinos K, Zamboglou C, Müller JA, Leucht C, Dickstein DR, Schnellhardt S, Haehl E, Hambsch P, Kuhnt T, Seidel C, Belka C, Mayer A, Schmidberger H, Grosu AL, Balermpas P, Stromberger C, Binder H, Quon H, Nicolay NH.
Rühle A, et al. Among authors: muller ja.
Radiother Oncol. 2024 Dec 24:110697. doi: 10.1016/j.radonc.2024.110697. Online ahead of print.
Radiother Oncol. 2024.
PMID: 39725066